Davide Mangioni

2.4k total citations
32 papers, 614 citations indexed

About

Davide Mangioni is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Davide Mangioni has authored 32 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 11 papers in Epidemiology and 6 papers in Molecular Medicine. Recurrent topics in Davide Mangioni's work include COVID-19 Clinical Research Studies (8 papers), Antibiotic Resistance in Bacteria (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Davide Mangioni is often cited by papers focused on COVID-19 Clinical Research Studies (8 papers), Antibiotic Resistance in Bacteria (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Davide Mangioni collaborates with scholars based in Italy, Switzerland and United States. Davide Mangioni's co-authors include Alessandra Bandera, Andrea Gori, Simone Villa, Andrea Lombardi, Mario Raviǵlione, Giorgio Bozzi, Antonio Muscatello, Valeria Castelli, Ernesto Jaramillo and Emanuele Palomba and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and The Journal of Infectious Diseases.

In The Last Decade

Davide Mangioni

31 papers receiving 602 citations

Peers

Davide Mangioni
Krutika Kuppalli United States
Waasila Jassat South Africa
Jonathan Nunez United States
Cuong Duy Vietnam
Marie E. Killerby United States
Abdulaziz Alhazmi Saudi Arabia
Davide Mangioni
Citations per year, relative to Davide Mangioni Davide Mangioni (= 1×) peers Frédérique Jacquérioz

Countries citing papers authored by Davide Mangioni

Since Specialization
Citations

This map shows the geographic impact of Davide Mangioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Davide Mangioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Davide Mangioni more than expected).

Fields of papers citing papers by Davide Mangioni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Davide Mangioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Davide Mangioni. The network helps show where Davide Mangioni may publish in the future.

Co-authorship network of co-authors of Davide Mangioni

This figure shows the co-authorship network connecting the top 25 collaborators of Davide Mangioni. A scholar is included among the top collaborators of Davide Mangioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Davide Mangioni. Davide Mangioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mangioni, Davide, Chiara Abbruzzese, Antonio Teri, et al.. (2025). AMRrounds: Carbapenem-resistant Acinetobacter baumannii in the intensive care unit—when resistance meets severity. JAC-Antimicrobial Resistance. 7(3). dlaf067–dlaf067. 1 indexed citations
2.
Lombardi, Andrea, Davide Mangioni, Giulia Renisi, et al.. (2025). Dealing With Antibiotic Prophylaxis in Lung Transplantation in the Era of Multidrug Resistance: The Milano Algorithm. Transplantation Proceedings. 57(2). 339–341. 1 indexed citations
3.
Biscarini, Simona, Davide Mangioni, Laura Alagna, et al.. (2024). Adverse events during intravenous fosfomycin therapy in a real-life scenario. Risk factors and the potential role of therapeutic drug monitoring. BMC Infectious Diseases. 24(1). 650–650. 4 indexed citations
4.
Mangioni, Davide, Andrea Lombardi, Linda Bussini, et al.. (2024). Increase in invasive group A streptococcal infections in Milan, Italy: a genomic and clinical characterization. Frontiers in Microbiology. 14. 1287522–1287522. 10 indexed citations
5.
Lombardi, Andrea, et al.. (2024). New Antibiotics Against Multidrug-Resistant Gram-Negative Bacteria in Liver Transplantation: Clinical Perspectives, Toxicity, and PK/PD Properties. Transplant International. 37. 11692–11692. 4 indexed citations
6.
Chinello, Clizia, Giulia Capitoli, Andrea Lombardi, et al.. (2023). Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation. International Journal of Molecular Sciences. 24(4). 3570–3570. 8 indexed citations
7.
Carrara, Elena, Paolo Grossi, Andrea Gori, et al.. (2023). How to tailor recommendations on the treatment of multi-drug resistant Gram-negative infections at country level integrating antibiotic stewardship principles within the GRADE-ADOLOPMENT framework. The Lancet Infectious Diseases. 24(2). e113–e126. 4 indexed citations
9.
Lombardi, Andrea, Davide Mangioni, Dario Consonni, et al.. (2021). Seroprevalence of anti-SARS-CoV-2 IgG among healthcare workers of a large university hospital in Milan, Lombardy, Italy: a cross-sectional study. BMJ Open. 11(2). e047216–e047216. 22 indexed citations
10.
Palomba, Emanuele, Marco Maggioni, Davide Mangioni, et al.. (2021). Congenital Hepatic Fibrosis as a Cause of Recurrent Cholangitis: A Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 1(3). 132–137. 1 indexed citations
11.
Castelli, Valeria, Andrea Lombardi, Emanuele Palomba, et al.. (2021). Immune Checkpoint Inhibitors in People Living with HIV/AIDS: Facts and Controversies. Cells. 10(9). 2227–2227. 24 indexed citations
12.
Lombardi, Andrea, Dario Consonni, Michele Carugno, et al.. (2020). Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy. Clinical Microbiology and Infection. 26(10). 1413.e9–1413.e13. 78 indexed citations
13.
Filocamo, Giovanni, Davide Mangioni, Paola Tagliabue, et al.. (2020). Use of anakinra in severe COVID-19: A case report. International Journal of Infectious Diseases. 96. 607–609. 53 indexed citations
14.
Elli, Luca, Alessandro Rimondi, Lucia Scaramella, et al.. (2020). Endoscopy during the Covid-19 outbreak: experience and recommendations from a single center in a high-incidence scenario. Digestive and Liver Disease. 52(6). 606–612. 15 indexed citations
15.
Lombardi, Andrea, Elena Trombetta, Alessandra Cattaneo, et al.. (2020). Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes. Frontiers in Immunology. 11. 560330–560330. 38 indexed citations
16.
Villa, Simone, Ernesto Jaramillo, Davide Mangioni, et al.. (2020). Stigma at the time of the COVID-19 pandemic. Clinical Microbiology and Infection. 26(11). 1450–1452. 94 indexed citations
17.
Mangioni, Davide, Giacomo Grasselli, Chiara Abbruzzese, et al.. (2019). Adjuvant treatment of severe varicella pneumonia with intravenous varicella zoster virus-specific immunoglobulins. International Journal of Infectious Diseases. 85. 70–73. 6 indexed citations
18.
Mangioni, Davide, et al.. (2016). Abdominal aortitis and aneurysm impending rupture during pneumococcal meningitis. The Lancet Infectious Diseases. 16(8). 980–980. 2 indexed citations
19.
Mangioni, Davide, Alessandra Bandera, Antonio Muscatello, et al.. (2014). Focal bone lesions in hiv-positive patient treated with tenofovir. BMC Infectious Diseases. 14(1). 131–131. 2 indexed citations
20.
Mangioni, Davide, Alessandro Soria, Laura Brighina, et al.. (2014). A case of classic neuromyelitis optica (Devic’s syndrome) triggered by pegylated-interferon α. BMC Pharmacology and Toxicology. 15(1). 56–56. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026